Bill
HF 667
Minnesota bill clarifies when Medical Assistance covers prescription drugs patients can obtain through private insurance, establishing cost-effectiveness standards.
HF 667 clarifies how Minnesota's Medical Assistance program determines coverage of prescription drugs when cost-effective health insurance alternatives exist. The bill establishes guidelines for when MA should cover drugs that patients may already have access to through private insurance coverage. This addresses situations where patients have dual coverage and questions arise about which payer should be responsible.
Prescription drug coverage decisions affect thousands of low-income Minnesotans who receive both Medical Assistance and private insurance. Unclear coverage rules can create delays in patient access to medications, disputes between insurers, and administrative confusion. Clarification reduces barriers to care and establishes consistent standards for how the state determines cost-effectiveness in drug coverage decisions.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
